To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The principle of informed consent obligates physicians to explain possible side effects when prescribing medications. This disclosure may itself induce adverse effects through expectancy mechanisms known as nocebo effects, contradicting the principle of nonmaleficence. Rigorous research suggests that providing patients with a detailed enumeration of every possible adverse event-especially subjective self-appraised symptoms-can actually increase side effects. Describing one version of what might happen (clinical "facts") may actually create outcomes that are different from what would have happened without this information (another version of "facts"). This essay argues that the perceived tension between balancing informed consent with nonmaleficence might be resolved by recognizing that adverse effects have no clear black or white "truth." This essay suggests a pragmatic approach for providers to minimize nocebo responses while still maintaining patient autonomy through "contextualized informed consent," which takes into account possible side effects, the patient being treated, and the particular diagnosis involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,676
On the Elicitation of Preferences for Alternative Therapies
McNeil, B. J., Pauker, S. G., Sox, H. C., & Tversky, A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205273062103 · Cited by 1,668
Ainslie, G. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9781139164191 · Cited by 955
Barsky, A. J., & Borus, J. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00016 · Cited by 950
Rethinking Informed Consent in Bioethics
Manson, N. C., & O'Neill, O. (2007) · doi:10.1017/cbo9780511814600 · Cited by 800
Nonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784 · cited 1×
“…effect can significantly increase various nonspecific symptoms and complaints, resulting in psychological distress, significant excess costs because of increased medication nonadherence, extra treatment visits, and additional medicines prescribed to treat the nocebo effects (Barsky et al. 2002).”
BackgroundPlacebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.34 · Cited by 637
When words are painful: unraveling the mechanisms of the nocebo effect
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.020 · Cited by 636 · cited 1×
“Such a nocebo response is thought to occur because of patients’ negative expectations, anticipations, and anxiety (Benedetti et al. 2007).”
BackgroundCommunicating Evidence for Participatory Decision Making
Epstein, R. M. (2004) · JAMA · doi:10.1001/jama.291.19.2359 · Cited by 628
Gillon, R. (2003) · Journal of Medical Ethics · doi:10.1136/jme.29.5.307 · Cited by 618
Drug-Related Morbidity and Mortality: A Cost-of-Illness Model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430180043006 · Cited by 616
Sham device v inert pill: randomised controlled trial of two placebo treatments
Kaptchuk, T. J., Stason, W. B., Davis, R. B., Legedza, A. R. T., Schnyer, R. N., Kerr, C. E., Stone, D. A., Nam, B. H., Kirsch, I., & Goldman, R. H. (2006) · BMJ · doi:10.1136/bmj.38726.603310.55 · Cited by 532
Self-citationHow Doctors Think: Clinical Judgment and the Practice of Medicine
Montgomery, K. (2005) · Cited by 448
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419 · cited 1×
“Verbally induced nocebo hyperalgesia has been shown to be associated with hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis, and both the hyperalgesia and the HPA hyperactivity were antagonized by a benzodiazepine, suggesting that anxiety plays a role (Benedetti et al. 2006).”
BackgroundFinasteride 5 mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon?
Mondaini, N., Gontero, P., Giubilei, G., Lombardi, G., Cai, T., Gavazzi, A., & Bartoletti, R. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00563.x · Cited by 299
The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health
Hahn, R. A. (1997) · Preventive Medicine · doi:10.1006/pmed.1996.0124 · Cited by 275
Can words hurt? Patient–provider interactions during invasive procedures
Lang, E. V., Hatsiopoulou, O., Koch, T., Berbaum, K., Lutgendorf, S., Kettenmann, E., Logan, H., & Kaptchuk, T. J. (2005) · Pain · doi:10.1016/j.pain.2004.12.028 · Cited by 272
Self-citationPsaty, B. M. (1990) · JAMA · doi:10.1001/jama.263.12.1653 · Cited by 268
A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect
Kong, J., Gollub, R. L., Polich, G., Kirsch, I., LaViolette, P., Vangel, M., Rosen, B., & Kaptchuk, T. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2944-08.2008 · Cited by 263
Self-citationSilvestri, A. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.016 · Cited by 251
Reidenberg, M. M., Lowenthal, D. T., & Sacks, R. (1968) · New England Journal of Medicine · doi:10.1056/nejm196809262791304 · Cited by 242
A systematic review of adverse events in placebo groups of anti-migraine clinical trials
Amanzio, M., Corazzini, L. L., Vase, L., & Benedetti, F. (2009) · Pain · doi:10.1016/j.pain.2009.07.010 · Cited by 232
Nocebo-Induced Hyperalgesia During Local Anesthetic Injection
Varelmann, D., Pancaro, C., Cappiello, E. C., & Camann, W. R. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181cc5727 · Cited by 224
Potentiation of placebo analgesia by proglumide
Benedetti, F., Amanzio, M., & Maggi, G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92938-x · Cited by 221
The consent form as a possible cause of side effects
Myers, M. G., Cairns, J. A., & Singer, J. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.142 · Cited by 219
O'Connor, A. M., Pennie, R. A., & Dales, R. E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00177-1 · Cited by 204
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202 · cited 2×
“Such nocebo effects can be severe enough to have patients withdraw from treatment: Between 4 and 26% of patients in trials randomized to the placebo group discontinue the placebo because of perceived adverse events (Amanzio et al. 2009; Rief et al. 2006; Rief et al. 2009).”
BackgroundDisclosure of Information to Patients in Medical Care
Faden, R. R., Becker, C., Lewis, C., Freeman, J., & Faden, A. I. (1981) · Medical Care · doi:10.1097/00005650-198107000-00003 · Cited by 180
Rief, W., Avorn, J., & Barsky, A. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.155 · Cited by 167
Assessing general side effects in clinical trials: reference data from the general population
Rief, W., Barsky, A. J., Glombiewski, J. A., Nestoriuc, Y., Glaesmer, H., & Braehler, E. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2067 · Cited by 165
Mitsikostas, D. D., Mantonakis, L., & Chalarakis, N. (2011) · Cephalalgia · doi:10.1177/0333102410391485 · Cited by 142
de la Cruz, M., Hui, D., Parsons, H. A., & Bruera, E. D. (2009) · Cancer · doi:10.1002/cncr.24751 · Cited by 135
Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines
Nestoriuc, Y., Orav, E. J., Liang, M. H., Horne, R., & BARSKY, A. J. (2010) · Arthritis Care & Research · doi:10.1002/acr.20160 · Cited by 132
Selective monitoring of physical sensations.
Pennebaker, J. W., & Skelton, J. A. (1981) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.41.2.213 · Cited by 132
Placebo and Nocebo in Cardiovascular Health
Olshansky, B. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.036 · Cited by 127
Mass psychogenic illness attributed to toxic exposure at a high school
Jones, T. F., Craig, A. S., Hoy, D., Gunter, E. W., Ashley, D. L., Barr, D. B., Brock, J. W., & Schaffner, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420206 · Cited by 111
Miller, F. G., & Colloca, L. (2011) · Metamedicine · doi:10.1007/s11017-011-9179-8 · Cited by 111
Nonspecific side effects of oral contraceptives: nocebo or noise?
Grimes, D. A., & Schulz, K. F. (2010) · Contraception · doi:10.1016/j.contraception.2010.06.010 · Cited by 107
Nocebo: The Power of Suggestibility
Spiegel, H. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0229 · Cited by 77
Limits to truth-telling: Neurologists’ communication in conversion disorder
Kanaan, R., Armstrong, D., & Wessely, S. C. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.05.021 · Cited by 74
Thyroxine: anatomy of a health scare
Faasse, K., Cundy, T., & Petrie, K. J. (2009) · BMJ · doi:10.1136/bmj.b5613 · Cited by 72
Davies, S., Jackson, P., Ramsay, L. E., & Ghahramani, P. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.592 · Cited by 64
Formal and effective autonomy in healthcare
Schwab, A. P. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.013391 · Cited by 46
Placebo expectations and the detection of somatic information
Geers, A. L., Wellman, J. A., Fowler, S. L., Rasinski, H. M., & Helfer, S. G. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9301-9 · Cited by 32
Nocebo-induced Hyperalgesia During Local Anesthetic Injection
Varelmann, D. J., Pancaro, C., Cappiello, E. C., & Camann, W. (2011) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000397164.02159.09 · Cited by 21
Nocebo Responses to Antihypertensive Medications
Stern, R. H. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00007.x · Cited by 8
Cited by
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Petrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309
A systematic review of factors that contribute to nocebo effects
Webster, R. K., Weinman, J., & Rubin, G. J. (2016) · Health Psychology · doi:10.1037/hea0000416 · Cited by 172
“Wells and Kaptchuk (2012) suggest the use of contextualised informed consent, whereby doctors should identify high risk patients and tailor the medication side effect information so that these patients only receive drug specific side effect information, which is less susceptible to the nocebo…”
BackgroundNestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U.-S., & Rief, W. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw266 · Cited by 103
Wendt, L., Albring, A., Benson, S., Engler, H., Engler, A., Hinney, A., Rief, W., Witzke, O., & Schedlowski, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107665 · Cited by 47
Metadata
- Authors
- Wells, R. E., & Kaptchuk, T. J.
- Venue
- The American Journal of Bioethics
- Publisher
- Informa UK Limited
- Published
- 2012-03
- Volume
- 12
- Issue
- 3
- Pages
- 22-29
- ISSN
- 1526-5161 (ISSN-L)
- 1536-0075
- OpenAlex
- W2171887841
- Cited by
- 271
- References
- 46
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.